Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease With Wearing-off Motor Fluctuations”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT01568047
What this trial is testing

Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 40
Testing effectiveness (Phase 2)Study completedNCT00165789
What this trial is testing

Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Inc. 75
Post-approval studies (Phase 4)Study completedNCT04990284
What this trial is testing

EArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 106
Very early researchNot Yet RecruitingNCT07214974
What this trial is testing

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

Who this might be right for
Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease Dementia+7 more
Noah Tech, Corp. 600
Testing effectiveness (Phase 2)Study completedNCT01172379
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

Who this might be right for
Parkinson's Disease
Eisai Limited 2
Post-approval studies (Phase 4)Study completedNCT02847442
What this trial is testing

Efficacy and Safety of Opicapone in Clinical Practice

Who this might be right for
Parkinson's Disease With Wearing-off Motor Fluctuations
Bial - Portela C S.A. 518
Large-scale testing (Phase 3)Ended earlyNCT03051607
What this trial is testing

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Who this might be right for
Idiopathic Parkinson Disease
Biotie Therapies Inc. 66
Testing effectiveness (Phase 2)Looking for participantsNCT07432958
What this trial is testing

Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Who this might be right for
Parkinson Disease
Appello Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT01634360
What this trial is testing

Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Inc. 185
Large-scale testing (Phase 3)Ended earlyNCT02453386
What this trial is testing

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

Who this might be right for
Idiopathic Parkinson's Disease
Biotie Therapies Inc. 449
Testing effectiveness (Phase 2)Ended earlyNCT00427011
What this trial is testing

E2007 In Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Eisai Inc. 25
Testing effectiveness (Phase 2)Study completedNCT01766258
What this trial is testing

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations

Who this might be right for
Parkinson's Disease
Orion Corporation, Orion Pharma 117
Testing effectiveness (Phase 2)Study completedNCT06055985
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
UCB Biopharma SRL 207